Biotechnology

MLV & Co affirms its Buy rating and $30 price target on Ligand Pharmaceuticals (NASDAQ: LGND) following the company's earnings results in a research report out today. In the report, MLV & Co writes, "On February 8, after market close, LGND reported a net gain in 4Q:11 of $4.8M and EPS of $...

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announced that results from the Phase II study of its Captisol-enabled, propylene glycol-free (PG-free) Melphalan program were featured this evening in a poster presentation at the combined annual meetings of the Center for International Blood...

Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced the closing of the sale of 1,425,000 shares of its common stock pursuant to the exercise in full of an option to purchase such shares granted to the underwriters of Neurocrine's previously announced public offering of common stock that...

Neurocrine Biosciences, Inc. (NASDAQ: NBIX) announced today that its VMAT2 inhibitor product candidate, NBI-98854, has been granted Fast Track designation by the U.S. Food and Drug Administration for the treatment of neuroleptic-induced tardive dyskinesia. The FDA's Fast Track program is designed...

Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced the pricing of an underwritten public offering of 9,500,000 shares of its common stock at a price to the public of $8.10 per share. The gross proceeds to Neurocrine from this offering, before deducting underwriting discounts and...

Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced that it is offering to sell shares of its common stock in an underwritten public offering. Jefferies & Company, Inc. and Deutsche Bank Securities Inc. are acting as joint book-running managers for this offering, Piper Jaffray & Co...

Metabolix shares are down more than 55% today after the company announced its joint venture with Archer Daniels had been terminated. Metabolix (NASDAQ: MBLX) announced that the Archer Daniels Midland Company (NYSE: ADM) has given notice of termination of the Telles, LLC joint venture for PHA...

Metabolix Inc (NASDAQ: MBLX) shares fell 45.74% to $3.25 in the pre-market trading. Archer Daniels Midland Co (NYSE: ADM) reported that it will end a biodegradable plastics joint venture with Metabolix. JDA Software Group Inc (NASDAQ: JDAS) moved down 14.36% to $28.09 in the pre-market session....

Piper Jaffray reiterates its Neutral rating on Metabolix (NASDAQ: MBLX) and lowers its price target ot $3 from $5 to reflect uncertainty in commercialization following ADM's dissolution of Telles. Piper Jaffray notes, "The announcement yesterday after market close that ADM terminated their vital...

Analysts at Robert W. Baird downgraded Xueda Education Group (NYSE: XUE) from “outperform” to “neutral.” XUE's shares closed at $3.65 yesterday. Xueda Education's trailing-twelve-month profit margin is 7.37%. Morgan Stanley downgraded Shutterfly Inc (NASDAQ: SFLY) from “overweight” to “equal-...